Skye Bioscience, Inc. Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
Skye Bioscience, Inc. (SKYE) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of $132.37 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2023-03-31
- Skye Bioscience, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2022 was $132.37K, a 532.85% increase from fiscal 2021.
- Skye Bioscience, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2021 was $20.92K, a 7.68% decline from fiscal 2020.
- Skye Bioscience, Inc. effective income tax rate reconciliation, other reconciling items, amount for fiscal 2020 was $22.66K.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month |
|---|---|
| 2022-12-31 | $132.37K 10-K · filed 2023-03-31 |
| 2021-12-31 | $20.92K 10-K · filed 2023-03-31 |
| 2020-12-31 | $22.66K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |